Drugs / Oba01
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06083870 | Dec 2023 → Jul 2025 overdue | non-small cell lung carcinoma | Lu Shun | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Oba01 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06083870 ↗ |
| Route | Intravenous | “by intravenous (IV) infusion” NCT06083870 ↗ |